AzTrials
AzTrials

Sleep QualityNCT05154032

Examining the Differential Effects of Traditional Float-REST on Sleep and Recovery

A study testing Traditional Float-REST Therapy in people with Sleep Quality, run by West Virginia University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this research study is to assess how the implementation of Float-REST affects sleep quality, sleep structure, nocturnal physiology, subjective wellness, recovery from stressors, and resultant effects on performance and well-being. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Quality
What is being tested?
Traditional Float-REST Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteUnited States
Study dates
2 Nov 2021to 24 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female 18-50 years of age

Who cannot join

  • Has undergone travel across more than two collective time zones in the last two weeks
  • Has a head diameter outside the range of 20.8-24 inches, or an approved head-mounted EEG device doesn't otherwise fit properly
  • Has undergone a float-REST session of any kind in the last 3 months
  • Has a fresh piercings that is less than 6 weeks old from scheduled session
  • Has a fresh tattoo that is less than 4 weeks old from scheduled float
  • Has an injury requiring an orthopedic cast (i.e. plaster or synthetic), irremovable splint or brace
Show all 30Show fewer
  • Is claustrophobic (fear of confined spaces)
  • Has a skin or respiratory sensitivity or allergy to chlorine, sulfate, and/or magnesium
  • Has a history of or is prone to motion sickness
  • Has had an episode of loss of consciousness in the last 6-months
  • Has had a concussion or traumatic brain injury in the last 6-months
  • Has a contagious skin condition Has skin ulcers, open rashes, incisions, stiches or large open wounds that could cause pain when exposed to saltwater
  • Has an irremovable medical port or catheter
  • Has had a seizure in the last 10 years
  • Has communicable diseases (e.g. HIV, Hepatitis A, B \& C, tuberculosis, or measles)
  • Lack of control of bodily functions prior to scheduled float
  • Is pregnant or actively trying to become pregnant
  • Has a known or diagnosed sleep disorder
  • Females who have become menopausal or are exhibiting signs or symptoms of becoming perimenopausal
  • Females who are unable to identify when their monthly menstrual period will occur
  • Individuals who work during the night shift or have significantly abnormal sleep schedule
  • Individuals who intend to have any significant medical procedures scheduled to occur within 12 weeks of enrollment
  • Individuals who have intentions, or have discussed with their doctor, about adding or making any alterations to their prescribed medications within 12 weeks of enrollment
  • Individuals who have any travel plans or other obligations within 12 weeks of enrollment that would prevent them from completing study requirements and attending required laboratory visits
  • Individuals who intend to make significant alterations to their sleeping patterns within 12 weeks of enrollment. This may include, but is not limited to, changes such as moving, getting a new mattress, having someone move in with them, etc.
  • Does not meet the ACSM's guidelines for exercise prescription. This is defined as:
  • Presenting with an absolute contraindication OR
  • Has a known cardiovascular, pulmonary, renal, metabolic disease, or other chronic illness
  • Presents with symptoms indicating cardiovascular, pulmonary, renal, or metabolic disease
  • presenting with two or more relative contraindications

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Rockefeller Neuroscience Institute at West Virginia University

    Morgantown, West Virginia, 26505

Other trials in United States

About this study

The objective of this research study is to assess how the implementation of Float-REST affects sleep quality, sleep structure, nocturnal physiology, subjective wellness, recovery from stressors, and resultant effects on performance and well-being.

Read the detailed description

Traditional flotation therapy (Float-REST; Flotation Restricted Environmental Stimulation Therapy) uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. Previous studies have examined the effects of sensory-deprivation tanks on both subjective (e.g., perceived stress and anxiety, self-reported muscle soreness) and objective measures of recovery (e.g., blood pressure, skill performance) though findings are incomplete and contradictory. Additionally, provided the growing understanding that sleep quality and quantity are at the forefront of ensuring optimal human performance states, compounded by the deleterious effects of high stress and anxiety on sleep, utilizing flotation therapy as a mechanism for enhancing sleep requires further investigation.

To identify whether Float-REST influences sleep and related behaviors, an eight week design will be executed that comprises an initial four weeks of baseline data collections followed by four weeks of intervention application and measure. Intervention will consist of three 60 minute Float-REST sessions per week, for the first three weeks of the intervention block (weeks 5-7 of the study). Data measures include wearable device monitoring, surveys, and brief cognitive tasks that are collected at various timepoints throughout the study (intake, monthly, weekly, daily, etc.).

Conditions
Sleep Quality
Being tested
Traditional Float-REST Therapy
Keywords
Sleep, Sensory Deprivation Tank, Wearable Technology
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Traditional Float-REST TherapyOther

    Also called Sensory Deprivation Tanks

    Traditional Float-REST therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. The room will contain an intercom that allows participants to communicate with study personnel in the event they need assistance. Participants will undergo 60 minute sessions three times a week for 3 weeks.

Study groups in NCT05154032
Study groupRoleWhat they receive
Traditional Float-REST TherapyExperimentalParticipants will utilize sensory deprivation tanks.
Receives: Other: Traditional Float-REST Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Nocturnal Heart Rate as measured by OURA Ring

    Heart rate (beats per minute) will be quantified throughout the night via the OURA ring.

    Measured: Daily from baseline through study completion at 8 weeks

  2. Change in Sleep Quantity as measured by Electroencephalography

    Sleep stage duration (and the cumulative sleep duration) will be quantified each night via the Dreem headband, which uses Electroencephalography (EEG) for automatic sleep stage scoring.

    Measured: Daily from baseline through study completion at 8 weeks

  3. Change in Subjective Sleep Quality

    A custom daily morning questionnaire will be used to record how a participant feels the quality of their sleep was the previous night (e.g. 1, very poor; 10 excellent). This questionnaire will be taken on the participants smartphone within 30 minutes of waking.

    Measured: Daily from baseline through study completion at 8 weeks

  4. Change in Nocturnal Heart Rate Variability as measured by OURA Ring

    Heart rate variability will be quantified throughout the night via the OURA ring.

    Measured: Daily from baseline through study completion at 8 weeks

  5. Change in Anxiety surrounding Float-REST as measured by the State Trait Anxiety Index

    Participants will complete the previously validated State Trait Anxiety Index (STAI) before and after each float session as a measure of subjective anxiety, where higher scores are suggestive of greater anxiety.

    State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions. Values range from 20 to 80, with higher scores representing more severe anxiety. Participants will complete the STAI questionnaire before and after each session. The sessions will take place during weeks 5-7.

    Measured: Before and after each float session (Weeks 5-7)

  6. Change in heart rate during Float-REST as measured via Electrocardiography

    Participants will be monitored throughout float sessions using a heart rate monitor that will capture trends in cardiovascular physiology throughout the session.

    Measured: During each float session (weeks 5-7)

  7. Change in heart rate variability during Float-REST as measured via Electrocardiography

    Participants will be monitored throughout float sessions using a heart rate monitor that will capture trends in cardiovascular physiology throughout the session.

    Measured: During each float session (weeks 5-7)

Secondary outcomes (17)
  1. Change in Subjective Athens Insomnia Scale measured via questionnaire

    Participants will complete previously validated questionnaires as often as once weekly throughout the study period (8 weeks).

    Athens Insomnia Scale (AIS) - eight-item questionnaire assessing sleep behaviors on a scale of 0 to 3. Higher scores = greater difficulty.

    Measured: Weekly throughout study completion at 8 weeks

  2. Change in Subjective Epworth Sleepiness Scale measured via questionnaire

    Participants will complete previously validated questionnaires as often as once weekly throughout the study period (8 weeks).

    Epworth Sleepiness Scale (ESS) - eight-item questionnaire assessing sleep behaviors on a scale of 0 to 3. Higher scores = increased average sleep propensity in daily life

    Measured: Weekly throughout study completion at 8 weeks

  3. Change in Subjective Insomnia Severity Index measured via questionnaire

    Participants will complete previously validated questionnaires as often as once weekly throughout the study period (8 weeks).

    Insomnia Severity Index (ISI) - seven-item questionnaire assessing sleep behaviors on a scale of 0 to 3. Higher scores = increased severity.

    Measured: Weekly throughout study completion at 8 weeks

  4. Change in Subjective Restorative Sleep Questionnaire

    Participants will complete previously validated questionnaires as often as once weekly throughout the study period (8 weeks).

    Restorative Sleep Questionnaire (RSQ) - nine-item questionnaire assessing sleep behaviors on a scale of 0 to 5. Higher scores = better sleep

    Measured: Weekly throughout study completion at 8 weeks

  5. Change in Subjective Patient Reported Outcomes Measurement Information System measured via questionnaire

    Participants will complete previously validated questionnaires as often as once weekly throughout the study period (8 weeks).

    Patient Reported Outcomes Measurement Information System (PROMIS) - seven item questionnaire assessing sleep behaviors on a scale of 0 to 5. Higher scores = healthier subject

    Measured: Weekly throughout study completion at 8 weeks

  6. Subjective Sleep Preferences

    At intake, a custom baseline questionnaire will be completed to record each participants sleep preferences and common behaviors. These sleep preferences will be used to identify if Float-REST tends to be more or less successful for certain individuals based upon predetermined qualities.

    Measured: Once at the beginning of week 1

  7. Subjective Success of Float-REST

    Following completion of the study, a custom questionnaire will record how successful the participant believes Float-REST was for improving their sleep and well-being. Participants will indicate how much they relate to a particular item on a scale of "Not at all" to "Very much so"

    Measured: Once at the end of week 8

  8. Changes in Conflict Management via Questionnaire

    Participants ability to manage conflict and the strategies in which they approach conflict will be assessed via the Conflict Management Questionnaire. This questionnaire scores the management of various situations based upon the participant responses (definitely true, true, tends to be true, tends not to be true, not true, definitely not true) and classifies the highest scoring response category as being the participant's preferred method of handing conflict. Scores of the response categories will be compared.

    Measured: Monthly from baseline through study completion at 8 weeks

  9. Changes in Emotional Regulation as measured via Emotional Regulation Questionnaire

    Participants' ability to regulate their emotions appropriately will be quantified via the previously validated Emotional Regulation Questionnaire (ERQ), in which participants will indicate how much they agree with each statement (1, strongly disagree; 7, strongly agree).

    Measured: Monthly from baseline through study completion at 8 weeks

  10. Changes in Perceived Stress as measured via Perceived Stress Scale

    Participants' perceived stress will be quantified via the previously validated Perceived Stress Scale (PSS), which asks participants to report on the frequency of various experiences (0, never; 4, very often) and final scoring suggests lower scores to be associated with lower levels of stress.

    Measured: Weekly from baseline through study completion at 8 weeks

  11. Changes in Subjective Sleep as measured via Pittsburgh Sleep Quality Index

    Participant's subjective reports of sleep quality will be quantified through the previously validated Pittsburgh Sleep Quality Index (PSQI). Questions are scored into multiple components to determine sleep difficulty in various areas, where higher scores are indicative of greater sleep difficulties; these scores will be compared across timepoints.

    Measured: Monthly from baseline through study completion at 8 weeks

  12. Changes in Subjective Anxiety as measured via the State Trait Anxiety Index

    Participants will complete the previously validated State Trait Anxiety Index (STAI) as a measure of subjective anxiety, where higher scores are suggestive of greater anxiety.

    Measured: Monthly from baseline through study completion at 8 weeks

  13. Changes in Sleep Disturbances as measured via the Sleep Disorders Questionnaire

    Participants will complete a 34 item checklist that has been previously used for screening of a potential sleep disorder; the more items that the participant feels applies to them, the higher the likelihood of the individual having a sleep disorder.

    Measured: Monthly from baseline through study completion at 8 weeks

  14. Change in Cognitive Performance via Stroop Task

    Participants will complete the Stroop Task at intake and once weekly throughout the study on a computer. The task requires participants to respond to the presentation of a word by clicking the key associated with the ink color rather than the meaning of the word. Participants will be monitored for speed and accuracy of responses.

    Measured: Weekly from baseline through study completion at 8 weeks.

  15. Change in Response Inhibition via SART 2

    Participants will complete the SART 2 task at intake and once weekly throughout the study on a computer. The task requires participants to respond, or refrain from responding, to the presentation of a number; a predetermined number is provided at the start of the task that participants are asked to refrain from responding to. Participants will be monitored for speed and accuracy of responses.

    Measured: Weekly from baseline through study completion at 8 weeks.

  16. Change in Attentional Vigilance via Mackworth Clock Task

    Participants will complete the Mackworth Clock task at intake and once weekly throughout the study on a computer. The task requires participants to watch the second hand of a clock across five minutes and respond as quickly as possible to skips in the clock's second hand by pressing a key. Participants will be monitored throughout the task for speed and accuracy of responses.

    Measured: Weekly from baseline through study completion at 8 weeks.

  17. Change in Mental Rotation via Computer Task

    Participants will complete the Mental Rotation task at intake and once monthly throughout the study on a computer. The task requires participants to respond as quickly as possible by select from two pictures that accurately depicts the same object that is presented in a different position in a third picture. 10 warm up trials will be completed followed by 10 test trials. Participants will be monitored throughout the task for speed and accuracy of responses.

    Measured: Monthly from baseline through study completion at 8 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2021
  2. Study start2 Nov 2021
  3. Primary completion1 Nov 2022
  4. Study completion24 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
All participants will complete the following design. Women who experience menstrual flow will be scheduled to ensure that flow occurs on weeks 4 and 8 for consistency. Baseline block (weeks 1-4): At intake, participants will complete up to 13 surveys, which includes two baseline questionnaires, \& the first rendition of weekly and monthly surveys. Participants will complete daily surveys each morning \& night, \& wear wearable devices to monitor physiology during sleep. Additionally, a laboratory visit will occur once per week for completion of weekly surveys \& cognitive assessments; monthly surveys will also be completed during the fourth week. Intervention block (weeks 5-8): Daily, weekly, \& monthly activities described for the baseline block will continue. Additionally, during weeks 5-7, participants will complete three 60-minute Float-REST sessions per week; The final week of this block will only involve the daily, weekly \& monthly activities plus an exit survey.
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05154032
Sponsor's protocol ID
2104298113
Status last verified
Apr 2025
First submitted
24 Sep 2021
Last updated
25 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Traditional Float-REST Therapy in people with Sleep Quality, run by West Virginia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 30 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Nocturnal Heart Rate as measured by OURA Ring (time frame: Daily from baseline through study completion at 8 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in